Lancet Neurology

The Lancet is a weekly peer-reviewed general medical journal. It is one of the world s best known, oldest, and most respected general medical journals. The Lancet was founded in 1823 by Thomas Wakley, an English surgeon who named it after the surgical instrument called a lancet, as well as after the term "lancet arch", a window with a sharp pointed arch, to indicate the "light of wisdom" or "to let in light". It publishes original research articles, review articles ("seminars" and "reviews"), editorials, book reviews, correspondence, as well as news features and case reports. The Lancet has been owned by Elsevier since 1991. As of 1995, the editor-in-chief is Richard Horton. The journal has editorial offices in London, New York, and Beijing. In the 2010 Journal Citation Reports, The Lancet s impact factor was ranked second among general medical journals, at 33.63, after The New England Journal of Medicine (53.48). The Lancet also has several speciality journals all bearing the parent title: The Lancet Neurology (neurology), The Lancet Oncology (oncology), and The Lancet Infectious Diseases (infectious diseases), all of which publish original research and reviews. These three

Publisher
Elsevier
History
1823–present
Website
http://www.thelancet.com/journals/lancet/issue/current
Impact factor
33.633 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Alzheimer's disease & dementia

Dementia with Lewy bodies: Unique genetic profile identified

Dementia with Lewy bodies has a unique genetic profile, distinct from those of Alzheimer's disease or Parkinson's disease, according to the first large-scale genetic study of this common type of dementia.

Alzheimer's disease & dementia

Cerebrovascular disease linked to Alzheimer's

While strokes are known to increase risk for dementia, much less is known about diseases of large and small blood vessels in the brain, separate from stroke, and how they relate to dementia. Diseased blood vessels in the ...

Alzheimer's disease & dementia

Withdrawing dementia drug doubles risk of nursing home placement

Withdrawing a commonly-prescribed Alzheimer's disease drug from people in the advanced stages of the disease doubles their risk of being placed in a nursing home within a year, according to UCL research published today in ...

Medical research

Paralysed man walks again with brain-controlled exoskeleton

A French man paralysed in a night club accident can walk again thanks to a brain-controlled exoskeleton in what scientists said Wednesday was a breakthrough providing hope to tetraplegics seeking to regain movement.

Neuroscience

Study reveals roots of Parkinson's in the brain

Researchers from King's College London have uncovered the earliest signs of Parkinson's disease in the brain, many years before patients show any symptoms. The results, published in The Lancet Neurology, challenge the traditional ...

page 1 from 21